Boston Scientific May Be Shielded From Weight-Loss Drugs Hit by Procedure Recovery Boston Scientific May Be Shielded From Weight-Loss Drugs Hit by Procedure Recovery

Boston Scientific ' s quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit from the surging popularity of weight-loss drugs.Reuters Health Information
Source: Medscape Orthopaedics Headlines - Category: Orthopaedics Tags: Diabetes & Endocrinology News Source Type: news